IDS Spotlights Next-Generation Immunoanalyzer at AACC 2019
By LabMedica International staff writers Posted on 05 Aug 2019 |
Image: The IDS-i10 next-generation immunoanalyzer (Photo courtesy of IDS).
Immunodiagnostic Systems {(IDS) Boldon, Tyne and Wear, United Kingdom} spotlighted its next-generation immunoanalyzer, the IDS-i10, at the AACC annual meeting and exhibition, which is the world’s largest scientific conference and tradeshow in the laboratory medicine field. This year marked the 71st edition of the scientific meeting and clinical lab expo, held from August 4-8, at the Anaheim Convention Center, in Anaheim, California, USA.
AACC provides a platform to connect with the world’s thought leaders in breaking laboratory medicine operating in fields including: clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine and lab management. As always, this year’s edition was full of technological advances as over 200 new product introductions were unveiled and demonstrated. Additionally, research developments and changes in the laboratory medicine field were discussed, in a variety of clinical areas, through an educational experience, which could be tailored by selecting from a range of scientific sessions.
IDS, a specialist in vitro diagnostic solution provider to the clinical laboratory market, develops, manufactures and markets innovative immunoassays and automated immunoanalyzer technologies to provide improved diagnostic outcomes for patients. At AACC 2019, IDS showcased its next generation immunoanalyzer, the IDS-i10, with faster testing capability and the capacity to connect to laboratory track systems, which can help medical professionals perform automated immunoassays more efficiently than ever. The chemiluminescence-based technology platform is entirely automated and offers continuous loading, as well as random access analysis.
AACC provides a platform to connect with the world’s thought leaders in breaking laboratory medicine operating in fields including: clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine and lab management. As always, this year’s edition was full of technological advances as over 200 new product introductions were unveiled and demonstrated. Additionally, research developments and changes in the laboratory medicine field were discussed, in a variety of clinical areas, through an educational experience, which could be tailored by selecting from a range of scientific sessions.
IDS, a specialist in vitro diagnostic solution provider to the clinical laboratory market, develops, manufactures and markets innovative immunoassays and automated immunoanalyzer technologies to provide improved diagnostic outcomes for patients. At AACC 2019, IDS showcased its next generation immunoanalyzer, the IDS-i10, with faster testing capability and the capacity to connect to laboratory track systems, which can help medical professionals perform automated immunoassays more efficiently than ever. The chemiluminescence-based technology platform is entirely automated and offers continuous loading, as well as random access analysis.
Latest AACC 2019 News
- Instrumentation Laboratory Presents New IVD Testing System
- Quidel Welcomes Newest Member of Triage Family
- ERBA Mannheim Unveils Next-Generation Automation
- Roche Demonstrates How Health Networks Are Driving Change in Labs and Beyond
- BioMérieux Spotlights Diagnostic Solutions in Use of Antibiotics
- Thermo Shows New Clinical Innovations
- Randox Launches New Innovations
- Streck Introduces Three New Antibiotic Resistance Detection Kits
- EKF Diagnostics Highlights Assay for Diabetes Patient Monitoring
- Sysmex America Exhibits New Products, Automation and Quality Solutions
- BBI Solutions Showcases Mobile Solutions Capabilities at AACC 2019
- MedTest Dx Releases New Product Line for Drugs of Abuse Testing
- Mesa Biotech Launches Molecular Test System at AACC 2019
- Ortho Clinical Diagnostics Highlights Groundbreaking Lab Technology
- Abbott Diagnostics Exhibits POC Diagnostics Solutions at AACC
- Beckman Coulter Demonstrates Latest Innovations in Lab Medicine